Michael Gernert

529 total citations
34 papers, 295 citations indexed

About

Michael Gernert is a scholar working on Immunology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Gernert has authored 34 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Rheumatology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Gernert's work include Systemic Sclerosis and Related Diseases (8 papers), Spondyloarthritis Studies and Treatments (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Michael Gernert is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Spondyloarthritis Studies and Treatments (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Michael Gernert collaborates with scholars based in Germany, United States and Japan. Michael Gernert's co-authors include Marc Schmalzing, Hans‐Peter Tony, Eva C. Schwaneck, Matthias Fröhlich, Peter Kranke, Jörg Wischhusen, Christopher Lotz, Quirin Notz, Tobias Schlesinger and Johannes Herrmann and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Michael Gernert

31 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gernert Germany 10 104 95 79 53 42 34 295
C Balakrishnan India 9 71 0.7× 45 0.5× 146 1.8× 42 0.8× 21 0.5× 40 282
Rolando Cimaz Italy 11 62 0.6× 33 0.3× 227 2.9× 56 1.1× 19 0.5× 19 363
Rochella A. Ostrowski United States 10 43 0.4× 50 0.5× 129 1.6× 68 1.3× 13 0.3× 14 282
Elizabeth Wallin United Kingdom 8 166 1.6× 32 0.3× 32 0.4× 27 0.5× 21 0.5× 13 355
Özlem Karabudak Türkiye 10 101 1.0× 48 0.5× 107 1.4× 17 0.3× 21 0.5× 21 294
A. Laíz Spain 10 84 0.8× 35 0.4× 128 1.6× 17 0.3× 21 0.5× 45 272
Georges El Hasbani Lebanon 11 82 0.8× 24 0.3× 113 1.4× 51 1.0× 52 1.2× 60 343
Keiji Fujimoto Japan 9 54 0.5× 38 0.4× 19 0.2× 76 1.4× 37 0.9× 33 284
Lilia Abbad France 10 106 1.0× 109 1.1× 40 0.5× 33 0.6× 14 0.3× 16 420
Amanda Saracino Australia 11 75 0.7× 136 1.4× 109 1.4× 52 1.0× 7 0.2× 17 358

Countries citing papers authored by Michael Gernert

Since Specialization
Citations

This map shows the geographic impact of Michael Gernert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gernert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gernert more than expected).

Fields of papers citing papers by Michael Gernert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gernert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gernert. The network helps show where Michael Gernert may publish in the future.

Co-authorship network of co-authors of Michael Gernert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gernert. A scholar is included among the top collaborators of Michael Gernert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gernert. Michael Gernert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gernert, Michael, Eva C. Schwaneck, & Marc Schmalzing. (2025). „T-large granular lymphocytic“-Leukämie und Felty-Syndrom bei rheumatoider Arthritis. Zeitschrift für Rheumatologie. 84(1). 48–56.
2.
Labinsky, Hannah, Martin Krusche, Peer Aries, et al.. (2024). Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study. Rheumatology International. 44(10). 2043–2053. 8 indexed citations
3.
Gernert, Michael, et al.. (2024). Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up study. Arthritis Research & Therapy. 26(1). 210–210. 1 indexed citations
4.
Labinsky, Hannah, Michael Gernert, Astrid Schmieder, et al.. (2024). The exercise-app Axia for axial spondyloarthritis enhances the home-based exercise frequency in axial spondyloarthritis patients – A cross-sectional survey. Rheumatology International. 44(6). 1143–1154. 12 indexed citations
5.
6.
7.
8.
Heidemeier, Anke, Andreas Rosenwald, Michael Gernert, et al.. (2023). Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib. RMD Open. 9(1). e002852–e002852. 1 indexed citations
9.
Gernert, Michael, Hans‐Peter Tony, Matthias Fröhlich, Eva C. Schwaneck, & Marc Schmalzing. (2022). Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab. Frontiers in Immunology. 12. 817893–817893. 9 indexed citations
10.
Gernert, Michael, et al.. (2022). Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy. Arthritis Research & Therapy. 24(1). 200–200. 11 indexed citations
11.
Schwaneck, Eva C., Regina Renner, Hans‐Peter Tony, et al.. (2021). Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors. Rheumatology International. 41(11). 1979–1986. 3 indexed citations
12.
Gernert, Michael, Matthias Fröhlich, Regina Renner, et al.. (2021). High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies. Frontiers in Immunology. 12. 789345–789345. 3 indexed citations
13.
Almanzar, Giovanni, et al.. (2021). Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions. Frontiers in Immunology. 12. 668095–668095. 9 indexed citations
14.
Gernert, Michael, Eva C. Schwaneck, Ann‐Christin Pecher, et al.. (2021). Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients. Frontiers in Immunology. 12. 723349–723349. 10 indexed citations
15.
Krone, Manuel, Hans‐Peter Tony, Micha Gawlik, et al.. (2021). Use of Complementary and Alternative Medicine in Patients with Primary Immunodeficiency: a Multicentric Analysis of 101 Patients. Journal of Clinical Immunology. 41(3). 585–594. 2 indexed citations
16.
Gernert, Michael, et al.. (2021). Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication. Rheumatology International. 42(8). 1373–1381. 4 indexed citations
17.
Gernert, Michael, Hans‐Peter Tony, Eva C. Schwaneck, Matthias Fröhlich, & Marc Schmalzing. (2020). Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation. Arthritis Research & Therapy. 22(1). 183–183. 11 indexed citations
18.
Notz, Quirin, Marc Schmalzing, Tobias Schlesinger, et al.. (2020). Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome—An Observational Pilot Study. Frontiers in Immunology. 11. 581338–581338. 75 indexed citations
19.
20.
Schmalzing, Marc, et al.. (2018). Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration. The Open Rheumatology Journal. 12(1). 152–159. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Balakrishnan Breakdown of academic impact, for papers by Rolando Cimaz Breakdown of academic impact, for papers by Rochella A. Ostrowski Breakdown of academic impact, for papers by Elizabeth Wallin Breakdown of academic impact, for papers by Özlem Karabudak Breakdown of academic impact, for papers by A. Laíz Breakdown of academic impact, for papers by Georges El Hasbani Breakdown of academic impact, for papers by Keiji Fujimoto Breakdown of academic impact, for papers by Lilia Abbad Breakdown of academic impact, for papers by Amanda Saracino
Rankless by CCL
2026